We’re a fast growing med-tech company, passionate about using research to improve the lives of people with epilepsy.
We work closely with people with lived experience of epilepsy and the medical teams that support them to ensure that our technologies are developed to meet the needs of those who can benefit most from them.
John has over 20 years’ experience spanning five Russell Group Universities. He is a world-leading epilepsy expert and an internationally recognised leader; recipient of a Miegunyah Distinguished Visiting Fellowship from the University of Melbourne (2015/16) and a graduate of the Wellcome Trust Research Leadership Development Programme (2018/19). John has pioneered research that develops mathematical models to understand the network mechanisms of seizures, publishing over 70 original research articles. He has a significant track record of delivering complex projects on time and on budget, supported by commercial, charity and research council income totalling in excess of £15M. John is the strategic lead for the company.
Wessel holds an Epilepsy Research UK Emerging Leader Fellowship. A mathematician by training, his first published paper was highlighted by the Lancet Neurology as a breakthrough study in epilepsy. Wessel is responsible for optimising and testing the clinical functionality of BioEP, as well as leading on scientific discovery and validation of future Neuronostics products.
Chrissie has over 20 years’ experience in charity and academic sectors, as well as in commercial publishing. She has significant experience and expertise in directing operations, project management and communications and marketing. Tenacious and solutions focused, she specialises in teambuilding and people systems, organisational development and process improvement. She has extensive experience of successfully managing distributed teams of academics, clinicians and researchers to meet commercial and project deadlines. In her most recent role, she directed operations in a substantial academic unit that grew from 10 to 40 researchers in 3 years with total funding in excess of £10M. Chrissie leads the operational elements of Neuronostics, including project management, HR, finances and marketing.
Ross has worked for over 15 years in the commercial IT sector. He has delivered project management, technical consultancy and business solutions for blue chip companies and national governments throughout the UK, Europe and North America. In addition to his deep technical knowledge, he has a strong track-record in business development and partnership management through the identification and creation of new products and services resulting in significant revenue streams. In his most recent role, he was Head of Professional Services for a Microsoft Gold Partner. Ross is responsible for the technical elements of implementing Neuronostics’ technologies.
Dan has 7 years’ experience in software and engineering fields and holds a BSc in Biochemistry. He has extensive experience of the whole software development cycle, from scoping, design, and architecture through to implementation and delivery. In addition to his technical prowess, Dan is also well versed in user experience design and brand design. Dan is responsible for the design and development of Neuronostics’ web and mobile applications.
Kasun has over 8 years of experience in Software Engineering as well as Research Engineering. He has worked in .NET based technologies and Microsoft certified for the SQL server. Kasun has previous experience in a research-based environment having worked as a Research Engineer at Nanyang Technological University in Singapore. Kasun is responsible for developing the software components in Neuronostics.
Luke is a Research Fellow at the Centre for Systems Modelling and Quantitative Biomedicine at the University of Birmingham working with Neuronostics. With a background in mathematics, Luke’s role involves using quantitative techniques to analyse clinical data and develop machine learning tools for Neuronostics products. Luke’s work in the field of Alzheimer’s disease and epilepsy has been published in several peer-reviewed scientific journals.
Leandro is a Research Fellow at the Centre for Systems Modelling and Quantitative Biomedicine at the University of Birmingham. Leandro has a background in physics and mathematics, and has been collaborating with Neuronostics to optimise the underpinning methods behind BioEP.